Firms
Theme

INV

Innventure, Inc. · NASDAQ

$0.3167USDCS band Weak

↓ $0.02 (5.04%)

Last close · Oct 23, 4:00 PM ET

Sign up free to see this.

Mkt Cap
$27.5M
Volume
67.7K
52W High
$7.86
52W Low
$0.2388
PE Ratio
—
Avg Vol
9.4M
As of 10/23/26
Div Yield
—
Beta
3.77
As of 10/23/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about INV?

Latest news

News ›

GlobeNewswire Inc.

INV INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of the October 27, 2026 Lead Plaintiff Deadline in the Innventure, Inc. Securities Class Action

A shareholder class action lawsuit has been filed against Innventure, Inc. (NASDAQ: INV) alleging that the company made false and misleading statements regarding its subsidiary Accelsius's transformative deal with DarkNX. The lawsuit claims there was no evidence of DarkNX constructing a large-scale AI data center, making Innventure's 2026 revenue and cash targets implausible. The lead plaintiff deadline is October 27, 2026.

GlobeNewswire Inc.

INV DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Innventure, Inc. Investors to Secure Counsel Before Important October 27 Deadline in Securities Class Action - INV

Rosen Law Firm is urging investors who purchased Innventure, Inc. securities between November 17, 2025 and August 13, 2026 to secure legal counsel before the October 27, 2026 lead plaintiff deadline. The lawsuit alleges that Innventure made materially false statements regarding Accelsius Holdings' transformative deal with DarkNX, which was unlikely to materialize, resulting in overstated revenue and cash flow targets for 2026.

GlobeNewswire Inc.

Bronstein, Gewirtz & Grossman LLC Urges Innventure, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Innventure, Inc. (NASDAQ: INV) alleging securities fraud. The complaint claims the company made false statements about its subsidiary Accelsius's transformative deal with DarkNX, which allegedly lacked credible evidence of execution, and that revenue targets for 2026 were not reasonably plausible. Investors who purchased securities between November 17, 2025 and August 13, 2026 are eligible to join the case, with a lead plaintiff deadline of October 27, 2026.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $INV · 0 threads

Sign in to post on $INV

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev